October 2003
Clinical Infectious Diseases;10/1/2003, Vol. 37 Issue 7, pi
Academic Journal
Reports developments related to infectious diseases in the U.S. as of October 2003. Evaluation of the degree and duration of vaccinia immunity after smallpox vaccination; Decision of the Centers for Disease Control and Prevention to suspend the tiered influenza vaccination schedule; Accounts on the cause of infections among competitive athletes.


Related Articles

  • EPIDEMIOLOGY.  // British Medical Journal;11/3/1979, Vol. 2 Issue 6198, p1155 

    Describes the complications of smallpox vaccination reported at the Communicable Diseases Surveillance Center in Great Britain from 1978 to 1979. Association of the smallpox outbreak with laboratory activities; Reasons for the outbreak; Case reports involving a child with infantile eczema.

  • Medical groups express concern over safety of smallpox vaccine. Parker, Che // AHA News;10/14/2002, Vol. 38 Issue 40, p3 

    Deals with the statement released by the American Medical Association on the potential health risks of a mass vaccination strategy. Volume of smallpox vaccine given by the U.S. Centers for Disease Control and Prevention; Discussion of communicable diseases in the U.S.; Complication of...

  • Smallpox: Take the Shot or Not? McEvoy, Mike // Fire Engineering;May2003 Supplement, Vol. 156, p22 

    Focuses on the debate over the need for smallpox vaccination in the U.S. Concern over the use of smallpox in biological terrorism; Details on the transmission of the virus; Risks associated with vaccination. INSET: Those who should not be vaccinated.

  • News. Kaye, Donald // Clinical Infectious Diseases;12/1/2001, Vol. 33 Issue 11, pi 

    Presents news briefs on infectious diseases as of December 2001. Dengue fever outbreak in Hawaii; Firm in North Carolina that will sell home anthrax test kits; Plan of the United States to stockpile smallpox vaccine.

  • Smallpox Vaccination and Adverse Reactions. Cono, Joanne; Casey, Christine G.; Bell, David M. // MMWR: Morbidity & Mortality Weekly Report;2/21/2003 Supplement, Vol. 52 Issue RR-4, p1 

    Presents a study that examined smallpox vaccination and its adverse reactions. Normal vaccination progression; Expected range of vaccine reactions; Transmission of vaccinia virus.

  • Adventitious Agents and Smallpox Vaccine in Strategic National Stockpile. Murphy, Frederick A.; Osburn, Bennie I. // Emerging Infectious Diseases;Jul2005, Vol. 11 Issue 7, p1086 

    In keeping with current standards, we urge that old smallpox vaccines that were made in animal skin and are still a key part of our strategic national stockpile be tested for adventitious infectious agents. The advisory especially applies to viruses that have the potential for zoonotic...

  • A word about vaccines: PCV7, flu, and smallpox. Asch-Goodkin, Judith // Contemporary Pediatrics;Jun2003, Vol. 20 Issue 6, p15 

    Provides information on pneumococcal conjugate vaccine (PCV7), flu vaccine and smallpox vaccine in the U.S. Priority of the American Academy of Pediatrics for PCV7 vaccination; Recommendations issued by the Advisory Committee on Immunization Practices of the U.S. Centers for Disease Control and...

  • Smallpox Vaccination Vaccinia: Its Occurrence and Prevention.  // Clinical Pediatrics;Feb1980, Vol. 19 Issue 2, p124 

    This article focuses on the adverse reactions to smallpox vaccinations, discussed in the June 15, 1979 issue of the "Morbidity and Mortality Weekly Report," by the Center for Disease Control of the Department of Health, Education and Welfare. There are no current medical epidemiologic reasons...

  • Critical Role of Perforin-dependent CD8+ T Cell Immunity for Rapid Protective Vaccination in a Murine Model for Human Smallpox. Kremer, Melanie; Suezer, Yasemin; Volz, Asisa; Frenz, Theresa; Majzoub, Monir; Hanschmann, Kay-Martin; Lehmann, Michael H.; Kalinke, Ulrich; Sutter, Gerd // PLoS Pathogens;Mar2012, Vol. 8 Issue 3, Special section p1 

    Vaccination is highly effective in preventing various infectious diseases, whereas the constant threat of new emerging pathogens necessitates the development of innovative vaccination principles that also confer rapid protection in a case of emergency. Although increasing evidence points to T...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics